Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 3436 AL 3450

Towards defining a rigidity-associated pathogenic pathway in idiopathic parkinsonism

Dobbs RJ, Charlett A, Dobbs SM, Weller C, Iguodala O, Smee C, Bowthorpe J, Taylor D, Bjarnason IT.

Neurodegener Dis. 2012;10(1-4):183-6. doi: 10.1159/000332807. Epub 2011 Dec 23.

Targeting SKP1, an ubiquitin E3 ligase component found decreased in sporadic Parkinson's disease

Mandel SA, Fishman-Jacob T, Youdim MB.

Neurodegener Dis. 2012;10(1-4):220-3. doi: 10.1159/000333223. Epub 2011 Dec 23.

Do Parkinson's disease patients disclose their adverse events spontaneously?

Perez-Lloret S, Rey MV, Fabre N, Ory F, Spampinato U, Montastruc JL, Rascol O.

Eur J Clin Pharmacol. 2012 May;68(5):857-65. doi: 10.1007/s00228-011-1198-x. Epub 2011 Dec 29.

Synaptic protein alterations in Parkinson's disease

Pienaar IS, Burn D, Morris C, Dexter D.

Mol Neurobiol. 2012 Feb;45(1):126-43. doi: 10.1007/s12035-011-8226-9. Epub 2011 Dec 29.

Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice

Park JS, Shin JA, Jung JS, Hyun JW, Van Le TK, Kim DH, Park EM, Kim HS.

J Pharmacol Exp Ther. 2012 Apr;341(1):59-67. doi: 10.1124/jpet.111.189035. Epub 2011 Dec 29.

Probing the bioinorganic chemistry of toxic metals in the mammalian bloodstream to advance human health

Gailer J.

J Inorg Biochem. 2012 Mar;108:128-32. doi: 10.1016/j.jinorgbio.2011.12.001. Epub 2011 Dec 13.

Sentence intelligibility before and after voice treatment in speakers with idiopathic Parkinson's disease

Cannito MP, Suiter DM, Beverly D, Chorna L, Wolf T, Pfeiffer RM.

J Voice. 2012 Mar;26(2):214-9. doi: 10.1016/j.jvoice.2011.08.014. Epub 2011 Dec 29.

Efficacy of mefloquine to progressive multifocal leukoencephalopathy initially presented with parkinsonism

Hirayama M, Nosaki Y, Matsui K, Terao S, Kuwayama M, Tateyama H, Yoshida M, Hashizume Y.

Clin Neurol Neurosurg. 2012 Jul;114(6):728-31. doi: 10.1016/j.clineuro.2011.12.010. Epub 2011 Dec 30.

Gastroparesis and Parkinson's disease: a systematic review

Heetun ZS, Quigley EM.

Parkinsonism Relat Disord. 2012 Jun;18(5):433-40. doi: 10.1016/j.parkreldis.2011.12.004. Epub 2011 Dec 29.

Motor learning benefits of self-controlled practice in persons with Parkinson's disease

Chiviacowsky S, Wulf G, Lewthwaite R, Campos T.

Gait Posture. 2012 Apr;35(4):601-5. doi: 10.1016/j.gaitpost.2011.12.003. Epub 2011 Dec 30.

Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models?

Song JX, Sze SC, Ng TB, Lee CK, Leung GP, Shaw PC, Tong Y, Zhang YB.

J Ethnopharmacol. 2012 Feb 15;139(3):698-711. doi: 10.1016/j.jep.2011.12.030. Epub 2011 Dec 29.

Subthalamic neuronal responses to cortical stimulation

Janssen ML, Zwartjes DG, Temel Y, van Kranen-Mastenbroek V, Duits A, Bour LJ, Veltink PH, Heida T, Visser-Vandewalle V.

Mov Disord. 2012 Mar;27(3):435-8. doi: 10.1002/mds.24053. Epub 2011 Dec 30.

PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson's disease

Lu CS, Lai SC, Wu RM, Weng YH, Huang CL, Chen RS, Chang HC, Wu-Chou YH, Yeh TH.

Am J Med Genet B Neuropsychiatr Genet. 2012 Mar;159B(2):183-91. doi: 10.1002/ajmg.b.32012. Epub 2011 Dec 27.

The use of rodent skilled reaching as a translational model for investigating brain damage and disease

Klein A, Sacrey LA, Whishaw IQ, Dunnett SB.

Neurosci Biobehav Rev. 2012 Mar;36(3):1030-42. doi: 10.1016/j.neubiorev.2011.12.010. Epub 2011 Dec 30.

Use of viral vectors to create animal models for Parkinson's disease

Löw K, Aebischer P.

Neurobiol Dis. 2012 Nov;48(2):189-201. doi: 10.1016/j.nbd.2011.12.038. Epub 2011 Dec 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias